The Recently Approved #Pune-based Gennova Biopharmaceuticals' Two-dose MRNA #COVID19 ... - Latest Tweet by IANS India

The recently approved #Pune-based Gennova Biopharmaceuticals' two-dose mRNA #COVID19 vaccine, expected to be soon available in the country, is likely to see low penetration in the Indian market, according to a report. pic.twitter.com/tAObxV5eaD— IANS (@ians_india) July 11, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)